Clinical Trials Directory

Trials / Unknown

UnknownNCT05851404

Management of Indeterminate Thyroid Nodules Across Different World Regions

Management of Indeterminate Thyroid Nodules Across Different World Regions: a Multicentric International Study

Status
Unknown
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
University of Cagliari · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Thyroid carcinoma (TC) is the most common endocrine malignancy, affecting 0.2-1.5% of individuals worldwide. The rising incidence rate of TC is mostly related to the expanding use of high-quality imaging techniques, with an increase in the detection of thyroid nodules. Fine needle aspiration cytology (FNAC) is the most accurate, rapid, safe, and cost-effective test for the evaluation of thyroid nodules, with high specificity and sensitivity. Nevertheless, FNAC is particularly unreliable in differentiating between benign and malignant nodules that fall under the category of indeterminate thyroid nodules (class III and class IV according to Bethesda Classification\[2\]). In fact, in these cases, the expected malignancy rates are 5-15% and 15-30%, respectively. Thus, most patients with indeterminate thyroid nodules undergo an operation that is indeed unnecessary, while representing a risk for surgical complications and a cost for health-care systems. We aim to evaluate different approaches to indeterminate nodules across different countries in the world.

Conditions

Interventions

TypeNameDescription
PROCEDUREThyroidectomyTotal thyroidectomy or lobectomy

Timeline

Start date
2023-04-25
Primary completion
2023-07-30
Completion
2023-09-15
First posted
2023-05-09
Last updated
2023-05-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05851404. Inclusion in this directory is not an endorsement.